《人工智能辅助宫颈细胞学诊断技术的应用及质量控制专家共识》解读

[摘 要]2023年12月中国妇幼保健协会和中国妇幼保健协会妇女病防治专业委员会共同发布了《人工智能辅助宫颈细胞学诊断技术的应用及质量控制专家共识》（以下简称《共识》）。本文旨在对《共识》进行解读，便于相关专业人员在工作中进一步理解和实践。

[关键词]人工智能；宫颈细胞学；宫颈癌筛查；应用；解读

Doi：10.3969/j.issn.1673-5293.2024.03.001

[中图分类号]R173

[文献标识码]A

[文章编号]1673-5293（2024）03-0001-04

Interpretation of expert consensus on application and quality control of artificial intelligence assisted diagnostic techniques for cervical cytology

ZHANG Xiaosong1，DU Yun2，DONG Yan3，BI Hui1

（1.Department of Obstetrics and Gynecology，Peking University First Hospital，Beijing 100034，China; 2.Department of Cytology，Hebei Tumor Hospital，Hebei Shijiazhuang 050011，China; 3.Artificial intelligence Project Office of Chinese Maternal and Child Health Association，Beijing 100089，China）

[Abstract] In December 2023，Chinese Maternal and Child Health Association and Women’s Disease Prevention and Control Professional Committee of Chinese Maternal and Child Health Association jointly launched “Expert consensus on application and quality control of artificial intelligence assisted diagnostic techniques for cervical cytology”（hereinafter referred to as the “Consensus”）.This article aims to interpret the “Consensus”，facilitating further understanding and implementation for relevant professionals in their work.

[Key words] artificial intelligence;cervical cytology;cervical cancer screening;application;interpretation

宫颈癌是威胁女性健康的主要恶性肿瘤之一，据统计2020年全球新发宫颈癌60.4万例，死亡34.2万例，中、低收入国家是高发地区[1]。（剩余7891字）